Positive stool samples by pathogen and study sites. by Amete Mihret Teshale (12072758)

Socio-demographic and clinical characteristics of participants by study site. by Amete Mihret Teshale (12072758)

The relationship between age-standardized DALYs due to hypertension-induced AA and the SDI. by Guanghui Yu (423945)

Comparison of markers of aging among PHIVAYA groups and healthy controls. by Maria Raffaella Petrara (4446358)

Stress-strain curves of freeze-thaw cycling sandstone under different loading rates. by Wenyu Lv (20139458)

The trend of ASDR for hypertension-related AA in global age groups from 2022 to 2050 predicted using the Bayesian age-period-cohort (BAPC) model. by Guanghui Yu (423945)

Comparison of circulating biomarkers among PHIVAYA subgroups. by Maria Raffaella Petrara (4446358)

Odds Ratio of multivariable analysis of factors for <i>Campylobacter species.</i> by Amete Mihret Teshale (12072758)

Comparison of HIV-DNA and cell-associated HIV-RNA levels among PHIVAYA subgroups. by Maria Raffaella Petrara (4446358)

Odds ratio of multivariable analysis of factors for non-typhoidal <i>Salmonella.</i> by Amete Mihret Teshale (12072758)

Odds ratio of multivariable analysis of factors for Shiga toxin-producing <i>Escherichia coli</i> (<i>stx</i> only). by Amete Mihret Teshale (12072758)

Comparison of immune and cellular markers of aging among PHIVAYA subgroups. by Maria Raffaella Petrara (4446358)

Odds ratio of multivariable analysis of factors for Shiga-toxin producing <i>Escherichia coli</i> (<i>stx</i> by Amete Mihret Teshale (12072758)

Gaussian model fitted of the number of dogs detections of SARS-CoV-2, depending on the cycle threshold (Ct) values of RT-qPCR tests for SARS-CoV-2. by Víctor M. Vidal-Martínez (18707335)

Schematic pathogenetic pathway of how persistent HIV reservoir may lead to premature aging and precocious onset of aging-related comorbidities. by Maria Raffaella Petrara (4446358)

Calibration of standards. by Asif Khan (1740271)

“…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.…”

Appearance of standards under UV 365 nm. by Asif Khan (1740271)

“…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.…”

HPLC-Chromatogram of methanol fraction. by Asif Khan (1740271)

“…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.…”

Effects of <i>B</i>.<i>erecta</i> on kidney profile test. by Asif Khan (1740271)

“…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.…”

Effects of <i>B</i>.<i>erecta</i> on Morris water maze test. by Asif Khan (1740271)

“…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.…”